<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05017948</url>
  </required_header>
  <id_info>
    <org_study_id>Pro2021001087</org_study_id>
    <nct_id>NCT05017948</nct_id>
  </id_info>
  <brief_title>Alleviating Geriatric Inpatients' Medication-related Iatrogenesis</brief_title>
  <acronym>AGING</acronym>
  <official_title>Alleviating Geriatric Inpatients' Medication-related Iatrogenesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying&#xD;
      the risk of a patient's medication regimen. High risk patients will be identified at hospital&#xD;
      discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up.&#xD;
      The hypothesis being tested is that a reduction in MWRS™ will lead to reduced 30-day&#xD;
      readmission.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of individuals with an emergency department visit or hospital readmission</measure>
    <time_frame>30 days after hospital discharge</time_frame>
    <description>Number of individuals with an emergency department visit or hospital readmission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in score between patients aged older and younger than 65 years</measure>
    <time_frame>At time of intervention</time_frame>
    <description>Comparison between age groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Iatrogenic Disease</condition>
  <condition>Risk Reduction</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Discharge medication regimen instructions will be provided upon discharge after being assessed using the MWRS, optimized, and assessed by the prescriber.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Discharge medication regimen instructions will be provided upon discharge after being assessed by the prescriber.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Risk score based intervention</intervention_name>
    <description>Targeted interventions based off of risk score software</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospital admission for at least 48 hours&#xD;
&#xD;
          -  Prescribed at least 5 medications at hospital discharge&#xD;
&#xD;
          -  Baseline medication risk score of 20 or more&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Reside greater than 25 miles from the index facility&#xD;
&#xD;
          -  Discharge to hospice&#xD;
&#xD;
          -  Discharge against medical advice&#xD;
&#xD;
          -  Patient expiration during initial hospitalization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luigi Brunetti, PhD</last_name>
    <phone>908-595-2645</phone>
    <email>luigi.brunetti@rwjbh.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Robert Wood Johnson University Hospital Somerset</name>
      <address>
        <city>Somerville</city>
        <state>New Jersey</state>
        <zip>08876</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Brunetti, PhD</last_name>
      <phone>908-595-2645</phone>
      <email>luigi.brunetti@rutgers.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Luigi Brunetti, PharmD, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iatrogenic Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results in publications, after deidentification (text, tables, figures, and appendices) will be shared.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning 9 months and ending 36 months following article publication.</ipd_time_frame>
    <ipd_access_criteria>Data will be shared with investigators whose proposed use of the data has been approved. Proposals should be directed to brunetti@rutgers.edu.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

